Confirmed Speakers

  • Sofia Agelaki, MD, PhD, Ass. Professor, Medical School, University of Crete, Greece.

  • Catherine Alix-Panabières, PhD, Laboratoire Cellules Circulantes Rares Humaines - LCCRH, Institut de Recherche en Biothérapie - IRB , Hôpital Saint-Eloi - CHRU Montpellier, France.

  • Alberto Bardelli, PhD, Institute for Cancer Research and Treatment, Department of Oncology, University of Torino, Candiolo, Italy

  • Richard J. Cote, M.D., FRCPath, Professor and Chair, Department of Pathology, University of Miami Miller School of Medicine, Miami, USA.

  • Massimo Cristofanilli, MD, FACP, Professor of Medicine, Associate Director of Translational Research and Precision Medicine, Department of Medicine-Hematology and Oncology, Robert H Lurie Comprehensive Cancer Center Feinberg School of Medicine, Chicago, IL, USA

  • Luis Diaz, MD, Associate Professor of Oncology, Johns Hopkins, University School of Medicine, Baltimore, MD USA

  • Caroline Dive, PhD, Professor , Deputy Director Cancer Research UK Manchester Institute, Senior Group Leader Clinical & Experimental Pharmacology, The University of Manchester, UK

  • Francoise Farace, PhD, Gustave Roussy, Université Paris-Saclay , "Circulating Tumor Cells" Translational Platform, CNRS UMS3655 - INSERM US23 AMMICA, F-94805, VILLEJUIF, France.

  • Maurizio Ferrari, MD, President of the International Federation of Clinical Chemistry (IFCC) Professor of Clinical Pathology University Vita-Salute San Raffaele Director of Clinical Molecular Biology and Cytogenetics Laboratory, Head of Unit Genomics for Diagnosis of Human Pathologies, IRCCS San Raffaele – Milan, Italy

  • Dave Hoon, M.Sc., Ph.D, Director, Department of Molecular Oncology, John Wayne cancer Institute, Santa Monica, CA, USA.

  • Michail Ignatiadis, MD, PhD, Ass. Professor, Jules Bordet Institute Brussels, Belgium

  • Maarten IJzerman, Professor, Health Technology & Services Research, University of Twente, the Netherlands

  • Stefanie S. Jeffrey, MD, John and Marva Warnock Professor, Department of Surgery, Chief of Surgical Oncology Research, Stanford University, School of Medicine, Stanford, USA

  • Raghu Kalluri MD, PhD, Department of Cancer Biology, Metastasis Research Center, University of Texas MD Anderson Cancer Center, Houston, TX, USA ,

  • Yibin Kang, PhD, Warner-Lambert/Parke-Davis Professor of Molecular Biology, Princeton University, Princeton, New Jersey, USA,

  • Sabine Kasimir-Bauer, PhD, Professor, Head of Laboratory, Dep. of Gynecology and Obstetrics, University Hospital of Essen, Germany.

  • Gary J. Kelloff, M.D., Special Advisor, CIP, DCTD, National Cancer Inst., NIH, USA

  • Peter Kuhn PhD, Dean’s Professor of Biological Sciences and Professor of Medicine, Biomedical Engineering, and Aerospace & Mechanical Engineering, Associate Director of The Bridge@USC Los Angeles, CA, USA

  • Lauren Leiman, PhD, Senior Director, External Partnerships at White House Cancer Moonshot Task Force, USA

  • Evi Lianidou PhD, Professor of Analytical Chemistry – Clinical Chemistry, Analysis of Circulating Tumor Cells lab, Dept of Chemistry, University of Athens, Greece

  • Dennis Lo, Professor, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China,

  • Mike Makrigiorgos PhD, Professor and Director, Medical Physics and Biophysics, Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA,

  • Bjorn Naume, Professor, Oslo University Hospital, Division of Surgery and Cancer Medicine, Department of Oncology, Oslo, Norway

  • Klaus Pantel, MD, PhD, Professor, Director, Institute of Tumour Biology, Centre of Experimental Medicine, University Medical Centre Hamburg Eppendorf, Hamburg, Germany

  • Jean-Yves Pierga, MD, PhD, Professor of Medical Oncology, at the Institute Curie and University Paris Descartes, Paris, France.

  • Brigitte Rack, MD, PhD, Department of Obstetrics and Gynecology, University of Ulm, Germany.

  • Thomas Schlange, PhD, Senior Biomarker Scientist, Global Biomarker Research, Bayer Pharma

  • Michael Speicher, MD, PhD, Institute of Human Genetics, Medical University of Graz, Austria

  • Leon Terstappen, PhD, Professor, Faculty of Science and Technology, MIRA Research Institute, Department of Medical Cell BioPhysics, University of Twente, the Netherlands.

  • Jean Paul Thiery, Professor, Research Director Comprehensive Cancer Center Institut Gustave Roussy, Villejuif, France

  • Danny R. Welch, PhD, Professor and Chair, Adjunct faculty of Department of Molecular & Integrative Physiology, University of Kansas Medical Center, Kansas City, USA.